Product
Current focus is in the development of beta-propiolactones and derivatives, using its proprietary Novo22™ catalyst.
Value
Solutions include a combination of catalytic innovation, cost reduction and carbon efficiency
Highlights
Strategic investors include Saudi Aramco, SABIC and DSM and financial investors include Flagship Ventures, OVP Ventures, and Physic Ventures